CASE REPORT
A 49-year-old pharmaceutical chemistry lecturer was admitted with suspected carbon monoxide and barbiturate poisoning having been seen to be well eight hours previously. He was a nonsmoker.
On examination the patient was obtunded, with a Glasgow Coma Scale of 5, flexing to painful stimuli. He was generally hypertonic with brisk reflexes and plantar withdrawal responses. His pupils were equal and responsive to light and a gag reflex was present. Vital signs were: blood pressure 150/95 mmHg, pulse 88 beats/minute, respirations 30/minute, temperature 38.4°C.
Investigations showed a carboxyhaemoglobin level of 8.7% (normal: nonsmoker 1-2%, smoker 10%) and a phenobarbitone level of 1.4 mg/l (therapeutic range 10-30 mg/I). Other urgent toxicology (alcohol, salicylates, paracetamol) was negative.
Initial management included high-flow oxygen and standard fluid treatment, associated with six-hourly intravenous bicarbonate maintaining his urine pH above 8 to aid excretion of the small amount of phenobarbitone found. Forced alkaline diuresis was considered unnecessary. The carboxyhaemoglobin level fell to < 2% over eight hours. However, the patient's neurological status remained unchanged for five days. On day 2 the patient required mechanical ventilation because of difficulty in maintaining an airway, hypercarbia and a staphylococcal chest infection. There was no problem with cardiovascular instability or hypothermia.
Neurology consultation confirmed a clinical picture consistent with CNS depressant intoxication. CT scan of the brain showed only mild cerebral oedema. EEG demonstrated the presence of an 'alpha coma'. Because of the clinical picture consistent with barbiturate poisoning, tablet fragments, found subsequently at the scene of the suicide attempt, were analysed.
Allobarbitone, a little known barbiturate of intermediate half-life and not detected on routine toxicology screen, was identified. There is a small degree of cross-reactivity in toxicology testing between allobarbitone and phenobarbitone, accounting for the level detected. Plasma levels were unhelpful as the toxic level is unknown. Subsequent questioning disclosed that the tablets had been manufactured by the patient's own students some twenty years previously.
After five days the patient's conscious state improved over a 24-hour period and he was extubated on day 6. This coincided with a fall in allobarbitone level. Eight days after admission the patient was discharged without neurological deficit.
DISCUSSION
Alpha coma has a number of aetiologies including brainstem stroke, hypoxic encephalopathy, toxic insult and head injury. 1·3 It has been reported that alpha coma carries a very poor prognosis. lA Claims have been made, however, that alpha waves on EEG in the presence of coma are non-specific, failing to differentiate extent and outcome of neurological insult. Rather, the initial neurological assessment and depth of coma is a better prognostic guideline. 3, 5 It has been suggested that alpha coma due to toxic insult forms an entirely different prognostic group than that due to other causes. 1·3,6,7 Further, the EEG in 'toxic' alpha coma may be significantly different from that due to other causes. 2 ,4,6 Our patient is of interest because, first, initial examination showed a light level of coma with intact brainstem function. Second, there was delay in the diagnosis of barbiturate overdose as the cause of the alpha coma. Third, there was total recovery after four days of ventilatory support.
Alpha coma due to toxic insult, unlike the alpha coma due to other causes, may not be associated with a poor prognosis. Patients presenting with alpha coma of unknown aetiology should be managed supportively while being fully investigated.
epileptic foci I and the persisting anticonvulsant activity of anaesthetics such as thiopentone and its metabolite pentobarbitone. 1 A prospective anaesthetic audit at The Amalgamated Melbourne and Essendon Hospitals during the period January 1981 to June 1986 reported that three patients had generalised seizures in the recovery room following neurosurgery. However, in the subsequent eighteen months, six
